{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T11:42:48Z","timestamp":1768563768975,"version":"3.49.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2012,3,27]],"date-time":"2012-03-27T00:00:00Z","timestamp":1332806400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1007\/s00228-012-1267-9","type":"journal-article","created":{"date-parts":[[2012,3,26]],"date-time":"2012-03-26T06:30:23Z","timestamp":1332743423000},"page":"1357-1363","source":"Crossref","is-referenced-by-count":24,"title":["Absorption of different oral dosage forms of oxycodone in the elderly: a cross-over clinical trial in patients undergoing cystoscopy"],"prefix":"10.1007","volume":"68","author":[{"given":"Merja","family":"Kokki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pyry","family":"V\u00e4litalo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilpo","family":"Rasanen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sirpa","family":"Aaltomaa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilkka","family":"Ojanper\u00e4","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matti","family":"Eskelinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannu","family":"Kokki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,3,27]]},"reference":[{"key":"1267_CR1","doi-asserted-by":"crossref","first-page":"47S","DOI":"10.1016\/j.jpainsymman.2005.01.010","volume":"29","author":"E Kalso","year":"2005","unstructured":"Kalso E (2005) Oxycodone. J Pain Symptom Manage 29:47S\u201356S","journal-title":"J Pain Symptom Manage"},{"key":"1267_CR2","doi-asserted-by":"crossref","first-page":"613","DOI":"10.2165\/00003088-200443090-00004","volume":"43","author":"H Kokki","year":"2004","unstructured":"Kokki H, Rasanen I, Reinikainen M, Suhonen P, Vanamo K, Ojanper\u00e4 I (2004) Pharmacokinetics of oxycodone after intravenous, buccal, intramuscular and gastric administration in children. Clin Pharmacokinet 43:613\u2013622","journal-title":"Clin Pharmacokinet"},{"key":"1267_CR3","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.amjopharm.2004.12.005","volume":"2","author":"B Cusack","year":"2004","unstructured":"Cusack B (2004) Pharmacokinetics in older persons. Am J Geriatr Pharmacother 2:274\u2013302","journal-title":"Am J Geriatr Pharmacother"},{"key":"1267_CR4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2165\/11586140-000000000-00000","volume":"28","author":"A Liukas","year":"2011","unstructured":"Liukas A, Kuusniemi K, Aantaa R, Virolainen P, Neuvonen M, Neuvonen PJ, Olkkola KT (2011) Elimination of intravenous oxycodone in the elderly: a pharmacokinetic study in postoperative orthopaedic patients of different age groups. Drug Aging 28:41\u201350","journal-title":"Drug Aging"},{"key":"1267_CR5","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.bpa.2006.12.005","volume":"21","author":"F Aubrun","year":"2007","unstructured":"Aubrun F, Marmion F (2007) The elderly patient and postoperative pain treatment. Best Pract Res Clin Anaesthesiol 21:109\u2013127","journal-title":"Best Pract Res Clin Anaesthesiol"},{"key":"1267_CR6","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1124\/pr.56.2.4","volume":"56","author":"AJ McLean","year":"2004","unstructured":"McLean AJ, Le Couteur DG (2004) Aging biology and geriatric clinical pharmacology. Pharmacol Rev 56:163\u2013184","journal-title":"Pharmacol Rev"},{"key":"1267_CR7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1001\/archinternmed.2008.525","volume":"169","author":"GH Gislason","year":"2009","unstructured":"Gislason GH, Rasmussen JN, Abildstrom SZ, Schramm TK, Hansen ML, Fosb\u00f8l EL et al (2009) Increased mortality and cardiovascular morbidity associated with use of nonsteroidal anti-inflammatory drugs in chronic heart failure. Arch Intern Med 169:141\u2013149","journal-title":"Arch Intern Med"},{"key":"1267_CR8","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1517\/17425255.1.1.33","volume":"1","author":"K Turnheim","year":"2005","unstructured":"Turnheim K (2005) Pharmacokinetic dosage guidelines for elderly subjects. Expert Opin Drug Metab Toxicol 1:33\u201348","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"1267_CR9","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2165\/00002512-200825040-00001","volume":"25","author":"LZ Kaestli","year":"2008","unstructured":"Kaestli LZ, Wasilewski-Rasca AF, Bonnabry P, Vogt-Ferrier N (2008) Use of transdermal drug formulations in the elderly. Drugs Aging 25:269\u2013280","journal-title":"Drugs Aging"},{"key":"1267_CR10","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/B978-0-443-06959-8.00033-9","volume-title":"Miller\u2019s anesthesia","author":"LA Fleisher","year":"2010","unstructured":"Fleisher LA (2010) Risk of anesthesia. In: Miller RD, Eriksson LI, Fleisher LA, Wiener-Kronish JP, Young WL (eds) Miller\u2019s anesthesia, 7th edn. Elsevier, Philadelphia, pp 969\u2013999","edition":"7"},{"key":"1267_CR11","doi-asserted-by":"crossref","first-page":"745","DOI":"10.2165\/00003088-200645070-00009","volume":"45","author":"H Kokki","year":"2006","unstructured":"Kokki H, Rasanen I, Laisalmi M, Lehtola S, Ranta VP, Vanamo K, Ojanper\u00e4 I (2006) Comparison of oxycodone pharmacokinetics after buccal and sublingual administration in children. Clin Pharmacokinet 45:745\u2013754","journal-title":"Clin Pharmacokinet"},{"key":"1267_CR12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0169-2607(98)00067-4","volume":"58","author":"EN Jonsson","year":"1999","unstructured":"Jonsson EN, Karlsson MO (1999) Xpose\u2014an S-PLUS based population pharmacokinetic\/pharmacodynamic model building aid for NONMEM. Comput Methods Programs Biomed 58:51\u201364","journal-title":"Comput Methods Programs Biomed"},{"key":"1267_CR13","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1046\/j.1365-2125.1996.00481.x","volume":"42","author":"JW Mandema","year":"1996","unstructured":"Mandema JW, Kaiko RF, Oshlack B, Reder RF, Stanski DR (1996) Characterization and validation of a pharmacokinetic model for controlled-release oxycodone. Br J Clin Pharmacol 42:747\u2013756","journal-title":"Br J Clin Pharmacol"},{"key":"1267_CR14","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1023\/A:1012299115260","volume":"28","author":"SL Beal","year":"2001","unstructured":"Beal SL (2001) Ways to fit a PK model with some data below the quantification limit. J Pharmacokinet Pharmacodyn 28:481\u2013504","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"1267_CR15","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1097\/ALN.0b013e31819faa54","volume":"110","author":"TH Nieminen","year":"2009","unstructured":"Nieminen TH, Hagelberg NM, Saari TI, Pertovaara A, Neuvonen M, Laine K, Neuvonen PJ, Olkkola KT (2009) Rifampin greatly reduces the plasma concentrations of intravenous and oral oxycodone. Anesthesiology 110:1371\u20131378","journal-title":"Anesthesiology"},{"key":"1267_CR16","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/clpt.1992.176","volume":"52","author":"KP Leow","year":"1992","unstructured":"Leow KP, Smith MT, Williams B, Cramond T (1992) Single-dose and steady-state pharmacokinetics and pharmacodynamics of oxycodone in patients with cancer. Clin Pharmacol Ther 52:487\u2013495","journal-title":"Clin Pharmacol Ther"},{"key":"1267_CR17","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1365-2125.1991.tb03942.x","volume":"32","author":"R P\u00f6yhi\u00e4","year":"1991","unstructured":"P\u00f6yhi\u00e4 R, Olkkola KT, Sepp\u00e4l\u00e4 T, Kalso E (1991) The pharmacokinetics of oxycodone after intravenous injection in adults. Br J Clin Pharmacol 32:516\u2013518","journal-title":"Br J Clin Pharmacol"},{"key":"1267_CR18","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1399-6576.1997.tb04684.x","volume":"41","author":"A Takala","year":"1997","unstructured":"Takala A, Kaasalainen V, Sepp\u00e4l\u00e4 T, Kalso E, Olkkola KT (1997) Pharmacokinetic comparison of intravenous and intranasal administration of oxycodone. Acta Anaesthesiol Scand 41:309\u2013312","journal-title":"Acta Anaesthesiol Scand"},{"key":"1267_CR19","first-page":"296","volume":"80","author":"KP Leow","year":"1995","unstructured":"Leow KP, Cramond T, Smith MT (1995) Pharmacokinetics and pharmacodynamics of oxycodone when given intravenously and rectally to adult patients with cancer pain. Anesth Analg 80:296\u2013302","journal-title":"Anesth Analg"},{"key":"1267_CR20","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/clpt.2008.64","volume":"84","author":"A Liukas","year":"2008","unstructured":"Liukas A, Kuusniemi K, Aantaa R, Virolainen P, Neuvonen M, Neuvonen PJ, Olkkola KT (2008) Plasma concentrations of oral oxycodone are greatly increased in the elderly. Clin Pharmacol Ther 84:462\u2013467","journal-title":"Clin Pharmacol Ther"},{"key":"1267_CR21","first-page":"961","volume":"3","author":"HH Villesen","year":"2007","unstructured":"Villesen HH, Banning AM, Petersen RH, Weinelt S, Poulsen JB, Hansen SH, Christrup LL (2007) Pharmacokinetics of morphine and oxycodone following intravenous administration in elderly patients. Ther Clin Risk Manag 3:961\u2013967","journal-title":"Ther Clin Risk Manag"},{"key":"1267_CR22","doi-asserted-by":"crossref","first-page":"276","DOI":"10.7326\/0003-4819-103-2-276","volume":"103","author":"AW Zimmer","year":"1985","unstructured":"Zimmer AW, Calkins E, Hadley E, Ostfeld AM, Kaye JM, Kaye D (1985) Conducting clinical research in geriatric populations. Ann Intern Med 103:276\u2013283","journal-title":"Ann Intern Med"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-012-1267-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-012-1267-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-012-1267-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T12:48:57Z","timestamp":1558702137000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-012-1267-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,27]]},"references-count":22,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["1267"],"URL":"https:\/\/doi.org\/10.1007\/s00228-012-1267-9","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,27]]}}}